Westend Capital Management, LLC Abb Vie Inc. Transaction History

Westend Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 14, 2025	SELL	$170.16 - $206.27 $101,925 - $123,555	-599 Reduced 5.38%	10,530 $1.95 Billion
Q1 2025 Apr 24, 2025	BUY	$169.2 - $216.66 $1.88 Million - $2.4 Million	11,097 Added 34678.13%	11,129 $2.33 Billion
Q2 2024 Jul 08, 2024	SELL	$154.79 - $180.76 $8,203 - $9,580	-53 Reduced 62.35%	32 $5.45 Million
Q1 2024 Apr 12, 2024	BUY	$159.82 - $182.1 $13,584 - $15,478	85 New	85 $15.5 Million

4,324

1.3B

16.1M

10.9M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $401B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Westend Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Westend Capital Management, LLC with notifications on news.